nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—OPRM1—alcohol dependence	0.198	0.427	CbGaD
Ondansetron—HTR1B—alcohol dependence	0.162	0.348	CbGaD
Ondansetron—OPRM1—Naltrexone—alcohol dependence	0.124	0.366	CbGbCtD
Ondansetron—CYP2E1—alcohol dependence	0.105	0.225	CbGaD
Ondansetron—CYP2E1—Disulfiram—alcohol dependence	0.0502	0.148	CbGbCtD
Ondansetron—CYP3A5—Disulfiram—alcohol dependence	0.039	0.115	CbGbCtD
Ondansetron—CYP2E1—Citalopram—alcohol dependence	0.0357	0.105	CbGbCtD
Ondansetron—CYP2C9—Disulfiram—alcohol dependence	0.0261	0.0772	CbGbCtD
Ondansetron—CYP1A2—Citalopram—alcohol dependence	0.0207	0.061	CbGbCtD
Ondansetron—CYP2D6—Citalopram—alcohol dependence	0.017	0.0503	CbGbCtD
Ondansetron—CYP3A4—Disulfiram—alcohol dependence	0.0152	0.0449	CbGbCtD
Ondansetron—CYP3A4—Citalopram—alcohol dependence	0.0108	0.032	CbGbCtD
Ondansetron—Alosetron—CYP2E1—alcohol dependence	0.00271	1	CrCbGaD
Ondansetron—HTR4—adrenal cortex—alcohol dependence	0.002	0.0575	CbGeAlD
Ondansetron—Tonic-clonic seizures—Citalopram—alcohol dependence	0.00182	0.0244	CcSEcCtD
Ondansetron—Procedural pain—Citalopram—alcohol dependence	0.00172	0.023	CcSEcCtD
Ondansetron—Movement disorder—Citalopram—alcohol dependence	0.00163	0.0218	CcSEcCtD
Ondansetron—HTR3A—nerve—alcohol dependence	0.00141	0.0404	CbGeAlD
Ondansetron—Hepatic failure—Disulfiram—alcohol dependence	0.00134	0.018	CcSEcCtD
Ondansetron—Shivering—Citalopram—alcohol dependence	0.00132	0.0177	CcSEcCtD
Ondansetron—OPRM1—nerve—alcohol dependence	0.00129	0.0371	CbGeAlD
Ondansetron—SLC47A2—digestive system—alcohol dependence	0.00115	0.033	CbGeAlD
Ondansetron—Laryngospasm—Acamprosate—alcohol dependence	0.0011	0.0147	CcSEcCtD
Ondansetron—Grand mal convulsion—Citalopram—alcohol dependence	0.00103	0.0138	CcSEcCtD
Ondansetron—Injection site pain—Naltrexone—alcohol dependence	0.000949	0.0127	CcSEcCtD
Ondansetron—Drowsiness—Disulfiram—alcohol dependence	0.00093	0.0125	CcSEcCtD
Ondansetron—Ear disorder—Citalopram—alcohol dependence	0.00091	0.0122	CcSEcCtD
Ondansetron—Anorectal discomfort—Citalopram—alcohol dependence	0.000898	0.012	CcSEcCtD
Ondansetron—HTR4—brain—alcohol dependence	0.000895	0.0257	CbGeAlD
Ondansetron—SLC47A2—nervous system—alcohol dependence	0.000887	0.0255	CbGeAlD
Ondansetron—Akathisia—Citalopram—alcohol dependence	0.000887	0.0119	CcSEcCtD
Ondansetron—Accommodation disorder—Citalopram—alcohol dependence	0.000855	0.0115	CcSEcCtD
Ondansetron—SLC47A2—central nervous system—alcohol dependence	0.000854	0.0246	CbGeAlD
Ondansetron—Injection site reaction—Naltrexone—alcohol dependence	0.000771	0.0103	CcSEcCtD
Ondansetron—Electrocardiogram QT prolonged—Citalopram—alcohol dependence	0.000765	0.0102	CcSEcCtD
Ondansetron—Torsade de pointes—Citalopram—alcohol dependence	0.0007	0.00938	CcSEcCtD
Ondansetron—SLC47A2—brain—alcohol dependence	0.000678	0.0195	CbGeAlD
Ondansetron—Sleep disorder—Naltrexone—alcohol dependence	0.00065	0.0087	CcSEcCtD
Ondansetron—Swelling—Naltrexone—alcohol dependence	0.000638	0.00854	CcSEcCtD
Ondansetron—Feeling hot—Citalopram—alcohol dependence	0.000626	0.00838	CcSEcCtD
Ondansetron—Myocardial ischaemia—Citalopram—alcohol dependence	0.000611	0.00818	CcSEcCtD
Ondansetron—HTR3A—brainstem—alcohol dependence	0.000603	0.0174	CbGeAlD
Ondansetron—Atrial fibrillation—Naltrexone—alcohol dependence	0.000594	0.00795	CcSEcCtD
Ondansetron—SLC47A1—brainstem—alcohol dependence	0.000593	0.017	CbGeAlD
Ondansetron—HTR3A—forebrain—alcohol dependence	0.000582	0.0167	CbGeAlD
Ondansetron—Cardiovascular disorder—Citalopram—alcohol dependence	0.000559	0.00749	CcSEcCtD
Ondansetron—OPRM1—brainstem—alcohol dependence	0.000553	0.0159	CbGeAlD
Ondansetron—Liver function test abnormal—Acamprosate—alcohol dependence	0.000549	0.00735	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.000536	0.00717	CcSEcCtD
Ondansetron—OPRM1—forebrain—alcohol dependence	0.000534	0.0154	CbGeAlD
Ondansetron—Paraesthesia—Disulfiram—alcohol dependence	0.000533	0.00714	CcSEcCtD
Ondansetron—SLC47A1—adrenal cortex—alcohol dependence	0.00053	0.0152	CbGeAlD
Ondansetron—Somnolence—Disulfiram—alcohol dependence	0.000527	0.00706	CcSEcCtD
Ondansetron—Dyskinesia—Citalopram—alcohol dependence	0.000523	0.007	CcSEcCtD
Ondansetron—Asthma—Acamprosate—alcohol dependence	0.000514	0.00688	CcSEcCtD
Ondansetron—Fatigue—Disulfiram—alcohol dependence	0.000512	0.00685	CcSEcCtD
Ondansetron—Pain—Disulfiram—alcohol dependence	0.000507	0.0068	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.000507	0.00679	CcSEcCtD
Ondansetron—HTR1B—brainstem—alcohol dependence	0.000506	0.0146	CbGeAlD
Ondansetron—Angina pectoris—Acamprosate—alcohol dependence	0.000501	0.00671	CcSEcCtD
Ondansetron—Musculoskeletal pain—Citalopram—alcohol dependence	0.000497	0.00666	CcSEcCtD
Ondansetron—Hiccups—Citalopram—alcohol dependence	0.000491	0.00658	CcSEcCtD
Ondansetron—HTR1B—forebrain—alcohol dependence	0.000488	0.0141	CbGeAlD
Ondansetron—CYP3A7—endocrine gland—alcohol dependence	0.000478	0.0137	CbGeAlD
Ondansetron—Angina pectoris—Naltrexone—alcohol dependence	0.000474	0.00634	CcSEcCtD
Ondansetron—Acute coronary syndrome—Acamprosate—alcohol dependence	0.000452	0.00605	CcSEcCtD
Ondansetron—Myocardial infarction—Acamprosate—alcohol dependence	0.000449	0.00602	CcSEcCtD
Ondansetron—Urinary tract infection—Acamprosate—alcohol dependence	0.000445	0.00597	CcSEcCtD
Ondansetron—SLC47A1—gonad—alcohol dependence	0.000439	0.0126	CbGeAlD
Ondansetron—CYP3A7—liver—alcohol dependence	0.000431	0.0124	CbGeAlD
Ondansetron—Acute coronary syndrome—Naltrexone—alcohol dependence	0.000427	0.00572	CcSEcCtD
Ondansetron—Asthenia—Disulfiram—alcohol dependence	0.000426	0.0057	CcSEcCtD
Ondansetron—Myocardial infarction—Naltrexone—alcohol dependence	0.000425	0.00569	CcSEcCtD
Ondansetron—Urinary tract infection—Naltrexone—alcohol dependence	0.000421	0.00564	CcSEcCtD
Ondansetron—Haemoglobin—Acamprosate—alcohol dependence	0.000413	0.00554	CcSEcCtD
Ondansetron—HTR1B—cardiovascular system—alcohol dependence	0.000413	0.0119	CbGeAlD
Ondansetron—Sleep disorder—Citalopram—alcohol dependence	0.000412	0.00552	CcSEcCtD
Ondansetron—Haemorrhage—Acamprosate—alcohol dependence	0.000411	0.00551	CcSEcCtD
Ondansetron—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00041	0.00549	CcSEcCtD
Ondansetron—HTR3A—digestive system—alcohol dependence	0.000409	0.0118	CbGeAlD
Ondansetron—HTR1A—brainstem—alcohol dependence	0.000408	0.0117	CbGeAlD
Ondansetron—SLC47A1—digestive system—alcohol dependence	0.000401	0.0115	CbGeAlD
Ondansetron—Hepatic failure—Citalopram—alcohol dependence	0.000397	0.00531	CcSEcCtD
Ondansetron—Visual impairment—Acamprosate—alcohol dependence	0.000396	0.00531	CcSEcCtD
Ondansetron—HTR1A—forebrain—alcohol dependence	0.000394	0.0113	CbGeAlD
Ondansetron—Dizziness—Disulfiram—alcohol dependence	0.000392	0.00525	CcSEcCtD
Ondansetron—HTR3A—blood—alcohol dependence	0.000389	0.0112	CbGeAlD
Ondansetron—SLC47A1—blood—alcohol dependence	0.000382	0.011	CbGeAlD
Ondansetron—Visual disturbance—Citalopram—alcohol dependence	0.000376	0.00504	CcSEcCtD
Ondansetron—Atrial fibrillation—Citalopram—alcohol dependence	0.000376	0.00504	CcSEcCtD
Ondansetron—Rash—Disulfiram—alcohol dependence	0.000374	0.00501	CcSEcCtD
Ondansetron—Headache—Disulfiram—alcohol dependence	0.000372	0.00498	CcSEcCtD
Ondansetron—Immune system disorder—Acamprosate—alcohol dependence	0.000372	0.00498	CcSEcCtD
Ondansetron—Chills—Acamprosate—alcohol dependence	0.000369	0.00494	CcSEcCtD
Ondansetron—CYP3A7-CYP3A51P—liver—alcohol dependence	0.000366	0.0105	CbGeAlD
Ondansetron—Eye disorder—Naltrexone—alcohol dependence	0.000364	0.00487	CcSEcCtD
Ondansetron—Cardiac disorder—Naltrexone—alcohol dependence	0.000361	0.00484	CcSEcCtD
Ondansetron—OPRM1—blood—alcohol dependence	0.000357	0.0103	CbGeAlD
Ondansetron—Angiopathy—Naltrexone—alcohol dependence	0.000353	0.00473	CcSEcCtD
Ondansetron—Flatulence—Acamprosate—alcohol dependence	0.000353	0.00473	CcSEcCtD
Ondansetron—OPRM1—midbrain—alcohol dependence	0.000352	0.0101	CbGeAlD
Ondansetron—Immune system disorder—Naltrexone—alcohol dependence	0.000352	0.00471	CcSEcCtD
Ondansetron—KCNH2—forebrain—alcohol dependence	0.000351	0.0101	CbGeAlD
Ondansetron—Mediastinal disorder—Naltrexone—alcohol dependence	0.000351	0.0047	CcSEcCtD
Ondansetron—Chills—Naltrexone—alcohol dependence	0.000349	0.00468	CcSEcCtD
Ondansetron—Urinary retention—Citalopram—alcohol dependence	0.000339	0.00454	CcSEcCtD
Ondansetron—Tremor—Acamprosate—alcohol dependence	0.000336	0.00449	CcSEcCtD
Ondansetron—Flatulence—Naltrexone—alcohol dependence	0.000334	0.00447	CcSEcCtD
Ondansetron—HTR1A—cardiovascular system—alcohol dependence	0.000333	0.00959	CbGeAlD
Ondansetron—Ill-defined disorder—Acamprosate—alcohol dependence	0.000332	0.00445	CcSEcCtD
Ondansetron—SLC47A1—endocrine gland—alcohol dependence	0.000332	0.00954	CbGeAlD
Ondansetron—Liver function test abnormal—Citalopram—alcohol dependence	0.000329	0.00441	CcSEcCtD
Ondansetron—Agitation—Acamprosate—alcohol dependence	0.000329	0.00441	CcSEcCtD
Ondansetron—Angioedema—Acamprosate—alcohol dependence	0.000327	0.00438	CcSEcCtD
Ondansetron—Hypokalaemia—Citalopram—alcohol dependence	0.000324	0.00435	CcSEcCtD
Ondansetron—Malaise—Acamprosate—alcohol dependence	0.000323	0.00433	CcSEcCtD
Ondansetron—HTR1B—midbrain—alcohol dependence	0.000323	0.00928	CbGeAlD
Ondansetron—Syncope—Acamprosate—alcohol dependence	0.000321	0.0043	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000321	0.0043	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000321	0.0043	CcSEcCtD
Ondansetron—Vision blurred—Naltrexone—alcohol dependence	0.000319	0.00428	CcSEcCtD
Ondansetron—Tremor—Naltrexone—alcohol dependence	0.000317	0.00425	CcSEcCtD
Ondansetron—Palpitations—Acamprosate—alcohol dependence	0.000316	0.00424	CcSEcCtD
Ondansetron—SLC47A1—testis—alcohol dependence	0.000316	0.0091	CbGeAlD
Ondansetron—HTR3A—nervous system—alcohol dependence	0.000316	0.00909	CbGeAlD
Ondansetron—Loss of consciousness—Acamprosate—alcohol dependence	0.000315	0.00422	CcSEcCtD
Ondansetron—Ill-defined disorder—Naltrexone—alcohol dependence	0.000314	0.00421	CcSEcCtD
Ondansetron—Cough—Acamprosate—alcohol dependence	0.000313	0.00419	CcSEcCtD
Ondansetron—Agitation—Naltrexone—alcohol dependence	0.000311	0.00417	CcSEcCtD
Ondansetron—SLC47A1—nervous system—alcohol dependence	0.00031	0.00893	CbGeAlD
Ondansetron—Convulsion—Acamprosate—alcohol dependence	0.00031	0.00416	CcSEcCtD
Ondansetron—Angioedema—Naltrexone—alcohol dependence	0.00031	0.00415	CcSEcCtD
Ondansetron—OPRM1—endocrine gland—alcohol dependence	0.00031	0.00891	CbGeAlD
Ondansetron—Asthma—Citalopram—alcohol dependence	0.000308	0.00413	CcSEcCtD
Ondansetron—Malaise—Naltrexone—alcohol dependence	0.000306	0.00409	CcSEcCtD
Ondansetron—Chest pain—Acamprosate—alcohol dependence	0.000305	0.00408	CcSEcCtD
Ondansetron—HTR3A—central nervous system—alcohol dependence	0.000304	0.00875	CbGeAlD
Ondansetron—Syncope—Naltrexone—alcohol dependence	0.000304	0.00407	CcSEcCtD
Ondansetron—Anxiety—Acamprosate—alcohol dependence	0.000304	0.00407	CcSEcCtD
Ondansetron—Bronchospasm—Citalopram—alcohol dependence	0.000303	0.00406	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000303	0.00406	CcSEcCtD
Ondansetron—Discomfort—Acamprosate—alcohol dependence	0.000301	0.00403	CcSEcCtD
Ondansetron—Angina pectoris—Citalopram—alcohol dependence	0.0003	0.00402	CcSEcCtD
Ondansetron—Palpitations—Naltrexone—alcohol dependence	0.000299	0.00401	CcSEcCtD
Ondansetron—SLC47A1—liver—alcohol dependence	0.000299	0.0086	CbGeAlD
Ondansetron—SLC47A1—central nervous system—alcohol dependence	0.000299	0.0086	CbGeAlD
Ondansetron—Dry mouth—Acamprosate—alcohol dependence	0.000298	0.00399	CcSEcCtD
Ondansetron—Loss of consciousness—Naltrexone—alcohol dependence	0.000298	0.00399	CcSEcCtD
Ondansetron—KCNH2—cardiovascular system—alcohol dependence	0.000297	0.00854	CbGeAlD
Ondansetron—Cough—Naltrexone—alcohol dependence	0.000296	0.00396	CcSEcCtD
Ondansetron—OPRM1—testis—alcohol dependence	0.000295	0.00849	CbGeAlD
Ondansetron—Convulsion—Naltrexone—alcohol dependence	0.000294	0.00393	CcSEcCtD
Ondansetron—Anaphylactic shock—Acamprosate—alcohol dependence	0.000292	0.00391	CcSEcCtD
Ondansetron—SLC47A1—cerebellum—alcohol dependence	0.000292	0.00841	CbGeAlD
Ondansetron—OPRM1—nervous system—alcohol dependence	0.00029	0.00834	CbGeAlD
Ondansetron—Chest pain—Naltrexone—alcohol dependence	0.000288	0.00386	CcSEcCtD
Ondansetron—Dysuria—Citalopram—alcohol dependence	0.000288	0.00386	CcSEcCtD
Ondansetron—Shock—Acamprosate—alcohol dependence	0.000288	0.00385	CcSEcCtD
Ondansetron—Anxiety—Naltrexone—alcohol dependence	0.000287	0.00385	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000286	0.00384	CcSEcCtD
Ondansetron—Tachycardia—Acamprosate—alcohol dependence	0.000285	0.00382	CcSEcCtD
Ondansetron—Discomfort—Naltrexone—alcohol dependence	0.000285	0.00382	CcSEcCtD
Ondansetron—Skin disorder—Acamprosate—alcohol dependence	0.000284	0.0038	CcSEcCtD
Ondansetron—HTR1B—endocrine gland—alcohol dependence	0.000283	0.00815	CbGeAlD
Ondansetron—Dry mouth—Naltrexone—alcohol dependence	0.000282	0.00378	CcSEcCtD
Ondansetron—OPRM1—central nervous system—alcohol dependence	0.000279	0.00803	CbGeAlD
Ondansetron—Anaphylactic shock—Naltrexone—alcohol dependence	0.000277	0.0037	CcSEcCtD
Ondansetron—Hypotension—Acamprosate—alcohol dependence	0.000273	0.00366	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000272	0.00365	CcSEcCtD
Ondansetron—Shock—Naltrexone—alcohol dependence	0.000272	0.00364	CcSEcCtD
Ondansetron—Nervous system disorder—Naltrexone—alcohol dependence	0.000271	0.00363	CcSEcCtD
Ondansetron—Acute coronary syndrome—Citalopram—alcohol dependence	0.000271	0.00363	CcSEcCtD
Ondansetron—Tachycardia—Naltrexone—alcohol dependence	0.00027	0.00361	CcSEcCtD
Ondansetron—Myocardial infarction—Citalopram—alcohol dependence	0.000269	0.00361	CcSEcCtD
Ondansetron—Skin disorder—Naltrexone—alcohol dependence	0.000269	0.0036	CcSEcCtD
Ondansetron—Urinary tract infection—Citalopram—alcohol dependence	0.000267	0.00358	CcSEcCtD
Ondansetron—HTR1B—nervous system—alcohol dependence	0.000265	0.00763	CbGeAlD
Ondansetron—Paraesthesia—Acamprosate—alcohol dependence	0.000262	0.00351	CcSEcCtD
Ondansetron—Dyspnoea—Acamprosate—alcohol dependence	0.000261	0.00349	CcSEcCtD
Ondansetron—HTR1A—midbrain—alcohol dependence	0.00026	0.00749	CbGeAlD
Ondansetron—Somnolence—Acamprosate—alcohol dependence	0.00026	0.00348	CcSEcCtD
Ondansetron—Hepatobiliary disease—Citalopram—alcohol dependence	0.00026	0.00348	CcSEcCtD
Ondansetron—HTR1B—central nervous system—alcohol dependence	0.000255	0.00734	CbGeAlD
Ondansetron—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000252	0.00338	CcSEcCtD
Ondansetron—Bradycardia—Citalopram—alcohol dependence	0.000251	0.00336	CcSEcCtD
Ondansetron—Constipation—Acamprosate—alcohol dependence	0.00025	0.00335	CcSEcCtD
Ondansetron—Pain—Acamprosate—alcohol dependence	0.00025	0.00335	CcSEcCtD
Ondansetron—Paraesthesia—Naltrexone—alcohol dependence	0.000248	0.00333	CcSEcCtD
Ondansetron—Haemoglobin—Citalopram—alcohol dependence	0.000248	0.00332	CcSEcCtD
Ondansetron—Haemorrhage—Citalopram—alcohol dependence	0.000247	0.0033	CcSEcCtD
Ondansetron—Dyspnoea—Naltrexone—alcohol dependence	0.000247	0.0033	CcSEcCtD
Ondansetron—Somnolence—Naltrexone—alcohol dependence	0.000246	0.00329	CcSEcCtD
Ondansetron—HTR3A—brain—alcohol dependence	0.000242	0.00695	CbGeAlD
Ondansetron—CYP2C9—cardiovascular system—alcohol dependence	0.000241	0.00694	CbGeAlD
Ondansetron—Feeling abnormal—Acamprosate—alcohol dependence	0.000241	0.00323	CcSEcCtD
Ondansetron—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000239	0.0032	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000239	0.0032	CcSEcCtD
Ondansetron—Fatigue—Naltrexone—alcohol dependence	0.000238	0.00319	CcSEcCtD
Ondansetron—CYP3A5—pancreas—alcohol dependence	0.000238	0.00685	CbGeAlD
Ondansetron—Visual impairment—Citalopram—alcohol dependence	0.000238	0.00318	CcSEcCtD
Ondansetron—SLC47A1—brain—alcohol dependence	0.000237	0.00683	CbGeAlD
Ondansetron—Pain—Naltrexone—alcohol dependence	0.000236	0.00317	CcSEcCtD
Ondansetron—Constipation—Naltrexone—alcohol dependence	0.000236	0.00317	CcSEcCtD
Ondansetron—KCNH2—blood—alcohol dependence	0.000235	0.00675	CbGeAlD
Ondansetron—Erythema multiforme—Citalopram—alcohol dependence	0.000233	0.00312	CcSEcCtD
Ondansetron—Urticaria—Acamprosate—alcohol dependence	0.000232	0.00311	CcSEcCtD
Ondansetron—KCNH2—midbrain—alcohol dependence	0.000232	0.00667	CbGeAlD
Ondansetron—Abdominal pain—Acamprosate—alcohol dependence	0.000231	0.00309	CcSEcCtD
Ondansetron—Body temperature increased—Acamprosate—alcohol dependence	0.000231	0.00309	CcSEcCtD
Ondansetron—Eye disorder—Citalopram—alcohol dependence	0.00023	0.00309	CcSEcCtD
Ondansetron—Cardiac disorder—Citalopram—alcohol dependence	0.000229	0.00307	CcSEcCtD
Ondansetron—Flushing—Citalopram—alcohol dependence	0.000229	0.00307	CcSEcCtD
Ondansetron—HTR1A—endocrine gland—alcohol dependence	0.000229	0.00658	CbGeAlD
Ondansetron—CYP2E1—cardiovascular system—alcohol dependence	0.000229	0.00657	CbGeAlD
Ondansetron—Feeling abnormal—Naltrexone—alcohol dependence	0.000228	0.00305	CcSEcCtD
Ondansetron—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000226	0.00303	CcSEcCtD
Ondansetron—Angiopathy—Citalopram—alcohol dependence	0.000224	0.003	CcSEcCtD
Ondansetron—Immune system disorder—Citalopram—alcohol dependence	0.000223	0.00298	CcSEcCtD
Ondansetron—Mediastinal disorder—Citalopram—alcohol dependence	0.000222	0.00298	CcSEcCtD
Ondansetron—CYP2D6—brainstem—alcohol dependence	0.000222	0.00638	CbGeAlD
Ondansetron—OPRM1—brain—alcohol dependence	0.000221	0.00637	CbGeAlD
Ondansetron—Chills—Citalopram—alcohol dependence	0.000221	0.00296	CcSEcCtD
Ondansetron—Arrhythmia—Citalopram—alcohol dependence	0.00022	0.00295	CcSEcCtD
Ondansetron—Urticaria—Naltrexone—alcohol dependence	0.00022	0.00294	CcSEcCtD
Ondansetron—Abdominal pain—Naltrexone—alcohol dependence	0.000219	0.00293	CcSEcCtD
Ondansetron—Body temperature increased—Naltrexone—alcohol dependence	0.000219	0.00293	CcSEcCtD
Ondansetron—Hypersensitivity—Acamprosate—alcohol dependence	0.000215	0.00288	CcSEcCtD
Ondansetron—Erythema—Citalopram—alcohol dependence	0.000215	0.00288	CcSEcCtD
Ondansetron—CYP2D6—forebrain—alcohol dependence	0.000214	0.00616	CbGeAlD
Ondansetron—HTR1A—nervous system—alcohol dependence	0.000214	0.00616	CbGeAlD
Ondansetron—Flatulence—Citalopram—alcohol dependence	0.000212	0.00283	CcSEcCtD
Ondansetron—CYP1A2—digestive system—alcohol dependence	0.000211	0.00607	CbGeAlD
Ondansetron—Asthenia—Acamprosate—alcohol dependence	0.00021	0.00281	CcSEcCtD
Ondansetron—Pruritus—Acamprosate—alcohol dependence	0.000207	0.00277	CcSEcCtD
Ondansetron—HTR1A—central nervous system—alcohol dependence	0.000206	0.00593	CbGeAlD
Ondansetron—Hypersensitivity—Naltrexone—alcohol dependence	0.000204	0.00273	CcSEcCtD
Ondansetron—KCNH2—endocrine gland—alcohol dependence	0.000204	0.00586	CbGeAlD
Ondansetron—CYP3A5—digestive system—alcohol dependence	0.000203	0.00585	CbGeAlD
Ondansetron—HTR1B—brain—alcohol dependence	0.000203	0.00583	CbGeAlD
Ondansetron—Vision blurred—Citalopram—alcohol dependence	0.000202	0.00271	CcSEcCtD
Ondansetron—HTR1A—cerebellum—alcohol dependence	0.000201	0.00579	CbGeAlD
Ondansetron—Tremor—Citalopram—alcohol dependence	0.000201	0.00269	CcSEcCtD
Ondansetron—CYP1A2—blood—alcohol dependence	0.000201	0.00578	CbGeAlD
Ondansetron—CYP2C9—digestive system—alcohol dependence	0.0002	0.00576	CbGeAlD
Ondansetron—Diarrhoea—Acamprosate—alcohol dependence	0.0002	0.00268	CcSEcCtD
Ondansetron—Ill-defined disorder—Citalopram—alcohol dependence	0.000199	0.00267	CcSEcCtD
Ondansetron—Asthenia—Naltrexone—alcohol dependence	0.000198	0.00266	CcSEcCtD
Ondansetron—Agitation—Citalopram—alcohol dependence	0.000197	0.00264	CcSEcCtD
Ondansetron—Angioedema—Citalopram—alcohol dependence	0.000196	0.00263	CcSEcCtD
Ondansetron—Pruritus—Naltrexone—alcohol dependence	0.000196	0.00262	CcSEcCtD
Ondansetron—KCNH2—testis—alcohol dependence	0.000194	0.00558	CbGeAlD
Ondansetron—CYP3A5—blood—alcohol dependence	0.000194	0.00557	CbGeAlD
Ondansetron—Malaise—Citalopram—alcohol dependence	0.000194	0.00259	CcSEcCtD
Ondansetron—Dizziness—Acamprosate—alcohol dependence	0.000193	0.00259	CcSEcCtD
Ondansetron—Syncope—Citalopram—alcohol dependence	0.000193	0.00258	CcSEcCtD
Ondansetron—CYP2C9—blood—alcohol dependence	0.000191	0.00549	CbGeAlD
Ondansetron—KCNH2—nervous system—alcohol dependence	0.00019	0.00548	CbGeAlD
Ondansetron—Palpitations—Citalopram—alcohol dependence	0.00019	0.00254	CcSEcCtD
Ondansetron—CYP2E1—digestive system—alcohol dependence	0.00019	0.00546	CbGeAlD
Ondansetron—Diarrhoea—Naltrexone—alcohol dependence	0.000189	0.00253	CcSEcCtD
Ondansetron—Loss of consciousness—Citalopram—alcohol dependence	0.000189	0.00253	CcSEcCtD
Ondansetron—Cough—Citalopram—alcohol dependence	0.000187	0.00251	CcSEcCtD
Ondansetron—Convulsion—Citalopram—alcohol dependence	0.000186	0.00249	CcSEcCtD
Ondansetron—Vomiting—Acamprosate—alcohol dependence	0.000186	0.00249	CcSEcCtD
Ondansetron—Rash—Acamprosate—alcohol dependence	0.000184	0.00247	CcSEcCtD
Ondansetron—Dermatitis—Acamprosate—alcohol dependence	0.000184	0.00247	CcSEcCtD
Ondansetron—KCNH2—central nervous system—alcohol dependence	0.000183	0.00528	CbGeAlD
Ondansetron—Headache—Acamprosate—alcohol dependence	0.000183	0.00245	CcSEcCtD
Ondansetron—Dizziness—Naltrexone—alcohol dependence	0.000183	0.00245	CcSEcCtD
Ondansetron—Chest pain—Citalopram—alcohol dependence	0.000183	0.00245	CcSEcCtD
Ondansetron—Anxiety—Citalopram—alcohol dependence	0.000182	0.00244	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000182	0.00243	CcSEcCtD
Ondansetron—CYP2E1—blood—alcohol dependence	0.000181	0.0052	CbGeAlD
Ondansetron—Discomfort—Citalopram—alcohol dependence	0.000181	0.00242	CcSEcCtD
Ondansetron—KCNH2—cerebellum—alcohol dependence	0.000179	0.00516	CbGeAlD
Ondansetron—Dry mouth—Citalopram—alcohol dependence	0.000179	0.00239	CcSEcCtD
Ondansetron—Vomiting—Naltrexone—alcohol dependence	0.000176	0.00235	CcSEcCtD
Ondansetron—Anaphylactic shock—Citalopram—alcohol dependence	0.000175	0.00235	CcSEcCtD
Ondansetron—Rash—Naltrexone—alcohol dependence	0.000174	0.00234	CcSEcCtD
Ondansetron—CYP1A2—endocrine gland—alcohol dependence	0.000174	0.00501	CbGeAlD
Ondansetron—Dermatitis—Naltrexone—alcohol dependence	0.000174	0.00233	CcSEcCtD
Ondansetron—Headache—Naltrexone—alcohol dependence	0.000173	0.00232	CcSEcCtD
Ondansetron—Shock—Citalopram—alcohol dependence	0.000172	0.00231	CcSEcCtD
Ondansetron—Nervous system disorder—Citalopram—alcohol dependence	0.000172	0.0023	CcSEcCtD
Ondansetron—Tachycardia—Citalopram—alcohol dependence	0.000171	0.00229	CcSEcCtD
Ondansetron—Skin disorder—Citalopram—alcohol dependence	0.00017	0.00228	CcSEcCtD
Ondansetron—CYP3A5—endocrine gland—alcohol dependence	0.000168	0.00484	CbGeAlD
Ondansetron—CYP2C9—endocrine gland—alcohol dependence	0.000165	0.00476	CbGeAlD
Ondansetron—Hypotension—Citalopram—alcohol dependence	0.000164	0.00219	CcSEcCtD
Ondansetron—HTR1A—brain—alcohol dependence	0.000164	0.00471	CbGeAlD
Ondansetron—Paraesthesia—Citalopram—alcohol dependence	0.000157	0.00211	CcSEcCtD
Ondansetron—CYP1A2—liver—alcohol dependence	0.000157	0.00452	CbGeAlD
Ondansetron—CYP2E1—endocrine gland—alcohol dependence	0.000157	0.00451	CbGeAlD
Ondansetron—Dyspnoea—Citalopram—alcohol dependence	0.000156	0.00209	CcSEcCtD
Ondansetron—Somnolence—Citalopram—alcohol dependence	0.000156	0.00209	CcSEcCtD
Ondansetron—CYP3A4—digestive system—alcohol dependence	0.000153	0.00439	CbGeAlD
Ondansetron—CYP3A5—liver—alcohol dependence	0.000152	0.00436	CbGeAlD
Ondansetron—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000151	0.00203	CcSEcCtD
Ondansetron—Fatigue—Citalopram—alcohol dependence	0.000151	0.00202	CcSEcCtD
Ondansetron—CYP2D6—digestive system—alcohol dependence	0.00015	0.00432	CbGeAlD
Ondansetron—Pain—Citalopram—alcohol dependence	0.00015	0.00201	CcSEcCtD
Ondansetron—Constipation—Citalopram—alcohol dependence	0.00015	0.00201	CcSEcCtD
Ondansetron—CYP2E1—testis—alcohol dependence	0.000149	0.0043	CbGeAlD
Ondansetron—CYP2C9—liver—alcohol dependence	0.000149	0.00429	CbGeAlD
Ondansetron—CYP2E1—nervous system—alcohol dependence	0.000147	0.00422	CbGeAlD
Ondansetron—KCNH2—brain—alcohol dependence	0.000146	0.00419	CbGeAlD
Ondansetron—CYP3A4—blood—alcohol dependence	0.000145	0.00418	CbGeAlD
Ondansetron—Feeling abnormal—Citalopram—alcohol dependence	0.000144	0.00193	CcSEcCtD
Ondansetron—Gastrointestinal pain—Citalopram—alcohol dependence	0.000143	0.00192	CcSEcCtD
Ondansetron—CYP2D6—blood—alcohol dependence	0.000143	0.00412	CbGeAlD
Ondansetron—CYP2E1—liver—alcohol dependence	0.000141	0.00407	CbGeAlD
Ondansetron—CYP2E1—central nervous system—alcohol dependence	0.000141	0.00406	CbGeAlD
Ondansetron—Urticaria—Citalopram—alcohol dependence	0.000139	0.00186	CcSEcCtD
Ondansetron—Abdominal pain—Citalopram—alcohol dependence	0.000139	0.00186	CcSEcCtD
Ondansetron—Body temperature increased—Citalopram—alcohol dependence	0.000139	0.00186	CcSEcCtD
Ondansetron—CYP2E1—cerebellum—alcohol dependence	0.000138	0.00397	CbGeAlD
Ondansetron—Hypersensitivity—Citalopram—alcohol dependence	0.000129	0.00173	CcSEcCtD
Ondansetron—CYP3A4—endocrine gland—alcohol dependence	0.000126	0.00363	CbGeAlD
Ondansetron—Asthenia—Citalopram—alcohol dependence	0.000126	0.00168	CcSEcCtD
Ondansetron—CYP2D6—endocrine gland—alcohol dependence	0.000124	0.00357	CbGeAlD
Ondansetron—Pruritus—Citalopram—alcohol dependence	0.000124	0.00166	CcSEcCtD
Ondansetron—Diarrhoea—Citalopram—alcohol dependence	0.00012	0.00161	CcSEcCtD
Ondansetron—CYP2D6—testis—alcohol dependence	0.000118	0.00341	CbGeAlD
Ondansetron—CYP3A4—nervous system—alcohol dependence	0.000118	0.0034	CbGeAlD
Ondansetron—CYP2D6—nervous system—alcohol dependence	0.000116	0.00334	CbGeAlD
Ondansetron—Dizziness—Citalopram—alcohol dependence	0.000116	0.00155	CcSEcCtD
Ondansetron—CYP3A4—liver—alcohol dependence	0.000114	0.00327	CbGeAlD
Ondansetron—CYP3A4—central nervous system—alcohol dependence	0.000114	0.00327	CbGeAlD
Ondansetron—CYP2E1—brain—alcohol dependence	0.000112	0.00323	CbGeAlD
Ondansetron—CYP2D6—liver—alcohol dependence	0.000112	0.00322	CbGeAlD
Ondansetron—CYP2D6—central nervous system—alcohol dependence	0.000112	0.00322	CbGeAlD
Ondansetron—Vomiting—Citalopram—alcohol dependence	0.000111	0.00149	CcSEcCtD
Ondansetron—Rash—Citalopram—alcohol dependence	0.00011	0.00148	CcSEcCtD
Ondansetron—Dermatitis—Citalopram—alcohol dependence	0.00011	0.00148	CcSEcCtD
Ondansetron—Headache—Citalopram—alcohol dependence	0.00011	0.00147	CcSEcCtD
Ondansetron—CYP2D6—cerebellum—alcohol dependence	0.000109	0.00315	CbGeAlD
Ondansetron—CYP2D6—brain—alcohol dependence	8.88e-05	0.00255	CbGeAlD
Ondansetron—HTR1A—GPCR downstream signaling—CRHR1—alcohol dependence	2.37e-05	0.000281	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—POMC—alcohol dependence	2.36e-05	0.00028	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ADH4—alcohol dependence	2.35e-05	0.000279	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CHRM2—alcohol dependence	2.35e-05	0.000278	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—PDYN—alcohol dependence	2.32e-05	0.000274	CbGpPWpGaD
Ondansetron—CYP1A2—Biological oxidations—GGT1—alcohol dependence	2.31e-05	0.000274	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—NPY—alcohol dependence	2.25e-05	0.000266	CbGpPWpGaD
Ondansetron—CYP2E1—Biological oxidations—POMC—alcohol dependence	2.24e-05	0.000266	CbGpPWpGaD
Ondansetron—CYP3A5—Biological oxidations—POMC—alcohol dependence	2.24e-05	0.000265	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CHRM2—alcohol dependence	2.23e-05	0.000264	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	2.23e-05	0.000264	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—EP300—alcohol dependence	2.23e-05	0.000264	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—AVP—alcohol dependence	2.2e-05	0.000261	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—NPY—alcohol dependence	2.18e-05	0.000259	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CRH—alcohol dependence	2.17e-05	0.000257	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CRHR1—alcohol dependence	2.15e-05	0.000255	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—HTR2A—alcohol dependence	2.12e-05	0.000252	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—OPRK1—alcohol dependence	2.12e-05	0.000252	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—HTR1B—alcohol dependence	2.11e-05	0.00025	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CRH—alcohol dependence	2.11e-05	0.00025	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—AVP—alcohol dependence	2.1e-05	0.000249	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—DRD4—alcohol dependence	2.09e-05	0.000247	CbGpPWpGaD
Ondansetron—CYP1A2—Biological oxidations—MAOA—alcohol dependence	2.07e-05	0.000245	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—OPRM1—alcohol dependence	2.05e-05	0.000243	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CHRM2—alcohol dependence	2.02e-05	0.00024	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ADH1A—alcohol dependence	2e-05	0.000237	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ADH7—alcohol dependence	2e-05	0.000237	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ADH1A—alcohol dependence	2e-05	0.000237	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CNR1—alcohol dependence	1.99e-05	0.000236	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—NPY—alcohol dependence	1.98e-05	0.000235	CbGpPWpGaD
Ondansetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	1.96e-05	0.000232	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—HTR7—alcohol dependence	1.94e-05	0.00023	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—DRD2—alcohol dependence	1.94e-05	0.00023	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	1.94e-05	0.00023	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	1.92e-05	0.000228	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—POMC—alcohol dependence	1.92e-05	0.000228	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GGT2—alcohol dependence	1.92e-05	0.000227	CbGpPWpGaD
Ondansetron—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	1.91e-05	0.000227	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CRH—alcohol dependence	1.91e-05	0.000227	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—HTR1B—alcohol dependence	1.91e-05	0.000227	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—DRD4—alcohol dependence	1.89e-05	0.000224	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—NPY—alcohol dependence	1.88e-05	0.000223	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—OPRD1—alcohol dependence	1.87e-05	0.000222	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—OPRM1—alcohol dependence	1.86e-05	0.00022	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—DRD4—alcohol dependence	1.84e-05	0.000218	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—HTR2A—alcohol dependence	1.83e-05	0.000217	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CRH—alcohol dependence	1.82e-05	0.000215	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—HTR1B—alcohol dependence	1.82e-05	0.000215	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CNR1—alcohol dependence	1.81e-05	0.000214	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PDYN—alcohol dependence	1.8e-05	0.000213	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—GGT1—alcohol dependence	1.78e-05	0.000211	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—DRD2—alcohol dependence	1.76e-05	0.000209	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—HTR7—alcohol dependence	1.76e-05	0.000209	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CNR1—alcohol dependence	1.76e-05	0.000208	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ADH1B—alcohol dependence	1.75e-05	0.000208	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—HTR2A—alcohol dependence	1.75e-05	0.000207	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ADH6—alcohol dependence	1.72e-05	0.000203	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—DRD2—alcohol dependence	1.71e-05	0.000203	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—HTR7—alcohol dependence	1.71e-05	0.000203	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—NPY—alcohol dependence	1.71e-05	0.000203	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ADH4—alcohol dependence	1.7e-05	0.000202	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ADH6—alcohol dependence	1.7e-05	0.000202	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ADH4—alcohol dependence	1.7e-05	0.000201	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—POMC—alcohol dependence	1.7e-05	0.000201	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—DRD4—alcohol dependence	1.67e-05	0.000198	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CRHR1—alcohol dependence	1.67e-05	0.000198	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—WASF2—alcohol dependence	1.67e-05	0.000198	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—OPRD1—alcohol dependence	1.65e-05	0.000196	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CRH—alcohol dependence	1.65e-05	0.000196	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—HTR1B—alcohol dependence	1.65e-05	0.000196	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—AVP—alcohol dependence	1.64e-05	0.000194	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—WASF1—alcohol dependence	1.6e-05	0.00019	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—MAOA—alcohol dependence	1.6e-05	0.000189	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CNR1—alcohol dependence	1.6e-05	0.000189	CbGpPWpGaD
Ondansetron—CYP2D6—Biological oxidations—POMC—alcohol dependence	1.59e-05	0.000188	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—DRD4—alcohol dependence	1.59e-05	0.000188	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PDYN—alcohol dependence	1.59e-05	0.000188	CbGpPWpGaD
Ondansetron—CYP2C9—Biological oxidations—POMC—alcohol dependence	1.58e-05	0.000187	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CHRM2—alcohol dependence	1.57e-05	0.000186	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—DRD2—alcohol dependence	1.56e-05	0.000185	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—HTR7—alcohol dependence	1.56e-05	0.000185	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CNR1—alcohol dependence	1.52e-05	0.00018	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—AVP—alcohol dependence	1.48e-05	0.000176	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—HTR7—alcohol dependence	1.48e-05	0.000175	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—DRD2—alcohol dependence	1.48e-05	0.000175	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—WASF2—alcohol dependence	1.47e-05	0.000175	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CRHR1—alcohol dependence	1.47e-05	0.000175	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—POMC—alcohol dependence	1.46e-05	0.000174	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ADH6—alcohol dependence	1.45e-05	0.000172	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—MAOB—alcohol dependence	1.45e-05	0.000172	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ADH7—alcohol dependence	1.45e-05	0.000172	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ADH7—alcohol dependence	1.45e-05	0.000171	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—AVP—alcohol dependence	1.44e-05	0.000171	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—DRD4—alcohol dependence	1.44e-05	0.000171	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—OPRM1—alcohol dependence	1.44e-05	0.000171	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—OPRD1—alcohol dependence	1.43e-05	0.000169	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ADH1A—alcohol dependence	1.42e-05	0.000169	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—WASF1—alcohol dependence	1.41e-05	0.000167	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ADH1A—alcohol dependence	1.41e-05	0.000167	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—POMC—alcohol dependence	1.4e-05	0.000165	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GGT2—alcohol dependence	1.39e-05	0.000165	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GGT2—alcohol dependence	1.39e-05	0.000164	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CHRM2—alcohol dependence	1.39e-05	0.000164	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CNR1—alcohol dependence	1.38e-05	0.000163	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PDYN—alcohol dependence	1.37e-05	0.000162	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—HTR2A—alcohol dependence	1.36e-05	0.000161	CbGpPWpGaD
Ondansetron—CYP1A2—Biological oxidations—POMC—alcohol dependence	1.35e-05	0.00016	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—DRD2—alcohol dependence	1.34e-05	0.000159	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—HTR7—alcohol dependence	1.34e-05	0.000159	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NPY—alcohol dependence	1.33e-05	0.000157	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—AVP—alcohol dependence	1.31e-05	0.000155	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CRH—alcohol dependence	1.28e-05	0.000152	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CRHR1—alcohol dependence	1.27e-05	0.000151	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—WASF2—alcohol dependence	1.27e-05	0.000151	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ADH1B—alcohol dependence	1.27e-05	0.000151	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ADH1B—alcohol dependence	1.27e-05	0.00015	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—AVP—alcohol dependence	1.25e-05	0.000148	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ALDH2—alcohol dependence	1.24e-05	0.000146	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—HTR2A—alcohol dependence	1.24e-05	0.000146	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—WASF1—alcohol dependence	1.22e-05	0.000145	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ADH4—alcohol dependence	1.21e-05	0.000143	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ADH1A—alcohol dependence	1.2e-05	0.000143	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—HTR2A—alcohol dependence	1.2e-05	0.000142	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ADH4—alcohol dependence	1.2e-05	0.000142	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CHRM2—alcohol dependence	1.2e-05	0.000142	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NPY—alcohol dependence	1.17e-05	0.000139	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—AVP—alcohol dependence	1.13e-05	0.000134	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HTR1B—alcohol dependence	1.13e-05	0.000134	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CRH—alcohol dependence	1.13e-05	0.000134	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ADH6—alcohol dependence	1.12e-05	0.000133	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—DRD4—alcohol dependence	1.12e-05	0.000133	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—OPRM1—alcohol dependence	1.1e-05	0.00013	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—HTR2A—alcohol dependence	1.09e-05	0.000129	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—POMC—alcohol dependence	1.09e-05	0.000129	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CNR1—alcohol dependence	1.07e-05	0.000127	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—MAOB—alcohol dependence	1.05e-05	0.000125	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GOT2—alcohol dependence	1.05e-05	0.000125	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—MAOB—alcohol dependence	1.05e-05	0.000124	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—HTR7—alcohol dependence	1.04e-05	0.000123	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—DRD2—alcohol dependence	1.04e-05	0.000123	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—POMC—alcohol dependence	1.04e-05	0.000123	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	1.04e-05	0.000123	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—HTR2A—alcohol dependence	1.04e-05	0.000123	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ADH7—alcohol dependence	1.03e-05	0.000122	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ADH4—alcohol dependence	1.02e-05	0.000121	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ADH7—alcohol dependence	1.02e-05	0.000121	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NPY—alcohol dependence	1.01e-05	0.00012	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CYP2E1—alcohol dependence	9.88e-06	0.000117	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—DRD4—alcohol dependence	9.87e-06	0.000117	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—POMC—alcohol dependence	9.87e-06	0.000117	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GGT2—alcohol dependence	9.86e-06	0.000117	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GGT2—alcohol dependence	9.77e-06	0.000116	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HTR1B—alcohol dependence	9.75e-06	0.000116	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CRH—alcohol dependence	9.75e-06	0.000116	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—POMC—alcohol dependence	9.59e-06	0.000114	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CNR1—alcohol dependence	9.43e-06	0.000112	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—HTR2A—alcohol dependence	9.41e-06	0.000112	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ADH1A—alcohol dependence	9.3e-06	0.00011	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—EP300—alcohol dependence	9.26e-06	0.00011	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HTR7—alcohol dependence	9.2e-06	0.000109	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—DRD2—alcohol dependence	9.2e-06	0.000109	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GGT1—alcohol dependence	9.07e-06	0.000107	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GOT1—alcohol dependence	9.07e-06	0.000107	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ADH1B—alcohol dependence	9.01e-06	0.000107	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ALDH2—alcohol dependence	8.95e-06	0.000106	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ADH1B—alcohol dependence	8.94e-06	0.000106	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ALDH2—alcohol dependence	8.93e-06	0.000106	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	8.87e-06	0.000105	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—AVP—alcohol dependence	8.77e-06	0.000104	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ADH7—alcohol dependence	8.71e-06	0.000103	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—POMC—alcohol dependence	8.71e-06	0.000103	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—DRD4—alcohol dependence	8.52e-06	0.000101	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GGT2—alcohol dependence	8.35e-06	9.89e-05	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—POMC—alcohol dependence	8.28e-06	9.81e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CNR1—alcohol dependence	8.14e-06	9.64e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—MAOA—alcohol dependence	8.13e-06	9.63e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—DRD2—alcohol dependence	7.94e-06	9.41e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HTR7—alcohol dependence	7.94e-06	9.41e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ADH4—alcohol dependence	7.9e-06	9.37e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AVP—alcohol dependence	7.74e-06	9.17e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ADH1B—alcohol dependence	7.64e-06	9.05e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GOT2—alcohol dependence	7.61e-06	9.02e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GOT2—alcohol dependence	7.59e-06	9e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—POMC—alcohol dependence	7.52e-06	8.91e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MAOB—alcohol dependence	7.47e-06	8.85e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MAOB—alcohol dependence	7.4e-06	8.78e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—HTR2A—alcohol dependence	7.3e-06	8.65e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP2E1—alcohol dependence	7.14e-06	8.46e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ADH7—alcohol dependence	6.72e-06	7.97e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AVP—alcohol dependence	6.68e-06	7.92e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GGT1—alcohol dependence	6.57e-06	7.79e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GOT1—alcohol dependence	6.57e-06	7.79e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GGT1—alcohol dependence	6.56e-06	7.77e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GOT1—alcohol dependence	6.56e-06	7.77e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GGT2—alcohol dependence	6.44e-06	7.64e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HTR2A—alcohol dependence	6.44e-06	7.63e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ALDH2—alcohol dependence	6.35e-06	7.53e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MAOB—alcohol dependence	6.33e-06	7.5e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ALDH2—alcohol dependence	6.3e-06	7.46e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	6.05e-06	7.17e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ADH1B—alcohol dependence	5.89e-06	6.98e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—MAOA—alcohol dependence	5.89e-06	6.98e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—MAOA—alcohol dependence	5.87e-06	6.96e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—POMC—alcohol dependence	5.83e-06	6.91e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HTR2A—alcohol dependence	5.56e-06	6.59e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GOT2—alcohol dependence	5.4e-06	6.4e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ALDH2—alcohol dependence	5.38e-06	6.38e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GOT2—alcohol dependence	5.35e-06	6.34e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—POMC—alcohol dependence	5.29e-06	6.27e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	5.17e-06	6.13e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—POMC—alcohol dependence	5.14e-06	6.1e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP2E1—alcohol dependence	5.08e-06	6.02e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP2E1—alcohol dependence	5.03e-06	5.97e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MAOB—alcohol dependence	4.88e-06	5.79e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GGT1—alcohol dependence	4.66e-06	5.52e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GOT1—alcohol dependence	4.66e-06	5.52e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GGT1—alcohol dependence	4.62e-06	5.48e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GOT1—alcohol dependence	4.62e-06	5.48e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GOT2—alcohol dependence	4.57e-06	5.42e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—POMC—alcohol dependence	4.44e-06	5.26e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP2E1—alcohol dependence	4.3e-06	5.1e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MAOA—alcohol dependence	4.18e-06	4.95e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALDH2—alcohol dependence	4.15e-06	4.92e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MAOA—alcohol dependence	4.14e-06	4.91e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	4.02e-06	4.76e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GOT1—alcohol dependence	3.95e-06	4.68e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GGT1—alcohol dependence	3.95e-06	4.68e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—EP300—alcohol dependence	3.87e-06	4.58e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—POMC—alcohol dependence	3.83e-06	4.54e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—POMC—alcohol dependence	3.82e-06	4.53e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MAOA—alcohol dependence	3.54e-06	4.19e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GOT2—alcohol dependence	3.53e-06	4.18e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—EP300—alcohol dependence	3.51e-06	4.16e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.43e-06	4.07e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—EP300—alcohol dependence	3.41e-06	4.04e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP2E1—alcohol dependence	3.32e-06	3.93e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GGT1—alcohol dependence	3.05e-06	3.61e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GOT1—alcohol dependence	3.05e-06	3.61e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—EP300—alcohol dependence	2.95e-06	3.49e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MAOA—alcohol dependence	2.73e-06	3.24e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—POMC—alcohol dependence	2.72e-06	3.22e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—POMC—alcohol dependence	2.7e-06	3.2e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—EP300—alcohol dependence	2.54e-06	3.01e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—EP300—alcohol dependence	2.54e-06	3.01e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—POMC—alcohol dependence	2.3e-06	2.73e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—EP300—alcohol dependence	1.8e-06	2.14e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—EP300—alcohol dependence	1.79e-06	2.12e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—POMC—alcohol dependence	1.78e-06	2.11e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—EP300—alcohol dependence	1.53e-06	1.81e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—EP300—alcohol dependence	1.18e-06	1.4e-05	CbGpPWpGaD
